Romosozumab and Denosumab, Alone or Combined, in Postmenopausal Osteoporosis

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Romosozumab and Denosumab, Alone or Combined, in Postmenopausal Osteoporosis	Bone Diseases, Metabolic, Nutritional and Metabolic Diseases, bone disorder, metabolic disease, musculoskeletal system disorder, osteoporosis	Recruiting	Phase 4	2025-12-16		NCT07283887

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Taiwan University Hospital	540

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
National Taiwan University Hospital Yunlin Branch	Douliu	Taiwan	2

Clinical trials